Federated Hermes, Inc. Eli Lilly & CO Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Federated Hermes, Inc. holds 368,518 shares of LLY stock, worth $289 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

368,518

Previous 265,162 38.98%

Holding current value

$289 Million

Previous $240 Million 35.99%

% of portfolio

0.75%

Previous 0.58%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $79.8 Million - $99.2 Million	103,356 Added 38.98%	368,518 $326 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $41.2 Million - $51.7 Million	56,855 Added 27.29%	265,162 $240 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $7.91 Million - $10.6 Million	-13,361 Reduced 6.03%	208,307 $162 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $75.2 Million - $88.7 Million	-143,244 Reduced 39.25%	221,668 $129 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $23.3 Million - $32.1 Million	-53,594 Reduced 12.81%	364,912 $196 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $10.8 Million - $14.5 Million	30,899 Added 7.97%	418,506 $196 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $21.4 Million - $25.1 Million	-68,846 Reduced 15.08%	387,607 $133 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $78.2 Million - $91.2 Million	243,334 Added 114.18%	456,453 $167 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $29.4 Million - $33.5 Million	99,114 Added 86.94%	213,119 $68.9 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $17.5 Million - $20.5 Million	62,661 Added 122.04%	114,005 $37 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $11,734 - $14,583	50 Added 0.1%	51,344 $14.7 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $20,236 - $25,113	90 Added 0.18%	51,294 $14.2 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $3.64 Million - $4.48 Million	-16,417 Reduced 24.28%	51,204 $11.8 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $15.4 Million - $19.9 Million	-85,302 Reduced 55.78%	67,621 $15.5 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $5.28 Million - $6.84 Million	-32,142 Reduced 17.37%	152,923 $28.6 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $2 Million - $2.65 Million	-15,367 Reduced 7.67%	185,065 $31.2 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $2.19 Million - $2.54 Million	-14,995 Reduced 6.96%	200,432 $29.7 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $30.5 Million - $36.7 Million	-223,415 Reduced 50.91%	215,427 $35.4 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $13 Million - $16.1 Million	109,484 Added 33.24%	438,842 $60.9 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $10 Million - $12.4 Million	93,730 Added 39.78%	329,358 $43.3 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $9.58 Million - $10.4 Million	-89,708 Reduced 27.57%	235,628 $26.4 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $22.8 Million - $26.6 Million	-205,973 Reduced 38.77%	325,336 $36 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $5.21 Million - $6.13 Million	-46,770 Reduced 8.09%	531,309 $68.9 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $26 Million - $29.1 Million	-245,638 Reduced 29.82%	578,079 $66.9 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $20.6 Million - $25.7 Million	239,612 Added 41.02%	823,717 $88.4 Million
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $14.6 Million - $16.7 Million	192,581 Added 49.19%	584,105 $49.8 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $7 Million - $8.26 Million	-94,328 Reduced 19.41%	391,524 $30.3 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $2 Million - $2.14 Million	24,384 Added 5.28%	485,852 $0
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $35.6 Million - $39.5 Million	461,468	461,468 $39.5 Million

Others Institutions Holding LLY

# of Institutions

4,033

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $746B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Eli Lilly & CO Transaction History